In a pivotal development this year, the U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) in August 2024 for emergency use in type 1 allergic reactions, such as anaphylaxis.
Manage symptoms with nasal sprays and OTC medications As pollen levels rise, nasal congestion, sneezing, and itchy eyes can become persistent issues. Nasal sprays and over-the-counter (OTC) ...